Proline?+?Dapagliflozin Tablets 50mg:5mg Price comparison
10 × $2.00 
Benidipine Hydrochloride Tablets (Sainiping) 8mg – For Laboratory Research Use Only
1 × $2.00 
Calcium Gluconate Tablets wholesale – Research Use Only
1 × $1.00 Subtotal: $23.00
$2.00
Yabang Hengbei Telmisartan Tablets contain 40?mg of the angiotensin?II receptor blocker per tablet, packaged in a 28-tablet box. Manufactured by Jiangsu Yabang Epsom Pharma, approved under NMPA H20041522. Ideal for hypertension, heart, and kidney preclinical studies.
?? For laboratory research only ?Please consult staff for other specifications and uses?
Telmisartan is a long-acting angiotensin II receptor blocker (ARB) used to study hypertension, cardiovascular protection, and renal health. It selectively blocks AT? receptors, producing vasodilation and reduced blood pressure. Telmisartan also partially activates PPAR??, enhancing insulin sensitivity and endothelial function
Yabang Hengbei Telmisartan Tablets are widely used in preclinical hypertension models, cardiovascular outcome research, and kidney injury studies.
| Parameter | Details |
|---|---|
| Product Name | Telmisartan Tablets (Yabang Hengbei) |
| Active Ingredient | Telmisartan |
| CAS Number | 144701-48-4 (Telmisartan) |
| Molecular Formula | C??H??N?O? |
| Molecular Weight | ~514.62?g/mol |
| Strength | 40?mg per tablet |
| Quantity per Box | 28 tablets |
| Dosage Form | Film-coated tablet |
| Approval Number | H20041522 (NMPA, China) |
| Manufacturer | Jiangsu Yabang Epsom Pharmaceutical Co., Ltd. |
| Barcode | 6934666301673 |
| Storage Conditions | Store ??25?°C, in a dry place away from light |
| Intended Use | Laboratory research on hypertension, cardiovascular & renal health |
Telmisartan blocks angiotensin II from binding to AT? receptors, reducing vasoconstriction and lowering blood pressure. It also partially activates PPAR??, which may improve insulin sensitivity and reduce tissue fibrosis
Hypertension and cardiovascular modeling
Renal protection and nephropathy studies
PPAR??–mediated metabolic and fibrotic pathways
Blood pressure pharmacodynamics
Combination therapy assessments with diuretics or calcium channel blockers
Use under standard lab protocols
Wear PPE (gloves, protective eyewear) during handling
Adverse effects in clinical models: dizziness, hypotension, hyperkalemia, renal impairment
Pregnancy/Fetal risk: Significant fetal harm if administered during the second or third trimester
Contraindications mimic clinical use: severe hepatic/renal impairment, pregnancy
Telmisartan tablets 40mg, CAS 144701-48-4, ARB hypertension research drug, Yabang Hengbei telmisartan, PPAR?? telmisartan, laboratory hypertension models, telmisartan pharmacology, wholesale telmisartan tablets, telmisartan research supply
This product is designated for laboratory and preclinical research only. It is not approved for clinical diagnosis, treatment, or human/veterinary use. Ensure all experimental protocols comply with regulatory and institutional guidelines.
| 重量 | 1 公斤 |
|---|---|
| 尺寸 | 26 × 23 × 26 厘米 |
Select at least 2 products
to compare
评价
目前还没有评价